Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan

Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan

Background: Epidermal growth factor receptor antagonists, such as gefitinib, erlotinib, and cetuximab, have been used in treating carcinomas. The efficacies have been proposed to correlate with skin reactions, but the most important predictive indicator is still unknown. Our aim was to investigate t...

Full description

Bibliographic Details
Main Authors: Shiou-Han Wang, Chih-Hsin Yang, Hsien-Ching Chiu, Fu-Chang Hu, Chih-Chieh Chan, Yi-Hua Liao, Hsiao-Chin Chen, Chia-Yu Chu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-03-01
Series:Dermatologica Sinica
Subjects:
Gefitinib
Non-small-cell lung cancer
Paronychia
Predictive factor
Skin toxicities (cutaneous adverse reactions)
Online Access:http://www.sciencedirect.com/science/article/pii/S1027811711000139

Internet

http://www.sciencedirect.com/science/article/pii/S1027811711000139

Similar Items